Collectively, these findings indicate that EC-specific deletion of Mlkl effectively alleviates liver fibrosis in NASH by suppressing the activation of the TGFβ/Smad 2/3 pathway and disrupting the pro-fibrotic crosstalk between endothelial cells and HSCs. Here, MLKL is linked to metabolic dysfunction-associated steatohepatitis.